Cardiff University | Prifysgol Caerdydd ORCA
Online Research @ Cardiff 
WelshClear Cookie - decide language by browser settings

Challenges for taking primary and stem cells into clinical neurotransplantation trials for neurodegenerative disease

Dunnett, Stephen Bruce ORCID: https://orcid.org/0000-0003-1826-1578 and Rosser, Anne Elizabeth ORCID: https://orcid.org/0000-0002-4716-4753 2014. Challenges for taking primary and stem cells into clinical neurotransplantation trials for neurodegenerative disease. Neurobiology of Disease 61 , pp. 79-89. 10.1016/j.nbd.2013.05.004

Full text not available from this repository.

Abstract

We review the first generations of clinical trials of novel cell therapies applied to a range of neurodegenerative diseases in the context of mechanisms of functional efficacy. This in turn helps to determine the best strategies to be adopted and the potential chances for success in developing new cell therapies to clinical application in different conditions. We then consider the scientific, technical, ethical, regulatory and logistic issues to be resolved in translating effective laboratory cell-based protocols to patients in clinical trials. We draw optimistic conclusions about the likelihood of success in developing radical new approaches to a range of devastating, and currently untreatable, neurodegenerative conditions, but caution that the problems are complex and the solutions are likely to be slow and costly to achieve in order to overcome significant ethical and regulatory as well as scientific challenges.

Item Type: Article
Date Type: Publication
Status: Published
Schools: Biosciences
MRC Centre for Neuropsychiatric Genetics and Genomics (CNGG)
Medicine
Neuroscience and Mental Health Research Institute (NMHRI)
Subjects: R Medicine > RC Internal medicine > RC0321 Neuroscience. Biological psychiatry. Neuropsychiatry
Uncontrolled Keywords: Cell therapy; Clinical trials; Clean rooms; Ethics; EU Tissue and Cells directive; Fetal tissues; First-in-man; GMP; Huntington's disease; Neural transplantation; Parkinson's disease; Regulatory compliance; Stem cells
Publisher: Elsevier
ISSN: 0969-9961
Last Modified: 24 Oct 2022 12:01
URI: https://orca.cardiff.ac.uk/id/eprint/50116

Citation Data

Cited 55 times in Scopus. View in Scopus. Powered By Scopus® Data

Actions (repository staff only)

Edit Item Edit Item